Associations among comorbid anxiety,psychiatric symptomatology,and diabetic control in a population with serious mental illness and diabetes: Findings from an interventional randomized controlled trial

Abstract

Objective

Serious mental illness and type II diabetes mellitus have a high comorbidity, and both have a higher prevalence of anxiety disorders compared to the general population. Targeted Training in Illness Management is a group-based self-management training approach which targets serious mental illness and type II diabetes mellitus concurrently. This analysis examines data from a randomized controlled trial of Targeted Training in Illness Management intervention to examine the impact of comorbid anxiety on baseline psychiatric symptomatology and diabetic control, and on longitudinal treatment outcomes.

Methods

We conducted secondary analyses on data from a prospective, 60-week, randomized controlled trial testing Targeted Training in Illness Management versus treatment as usual in 200 individuals with serious mental illness and diabetes. Primary outcomes included measures related to serious mental illness symptoms, functional status, general health status, and diabetes control. Measures were compared between those participants with anxiety disorders versus those without anxiety at baseline as well as over time using linear mixed effects analyses.

Results

Forty seven percent of the participants had one or more anxiety disorders. At baseline, those with an anxiety diagnosis had higher illness severity, depressive, and other psychiatric symptomatology and disability. Diabetic control (HbA1c) was not significantly different at baseline. In the longitudinal analyses, no significant mean slope differences over time (group-by-time interaction effect) between those with anxiety diagnoses and those without in treatment as usual group were found for primary outcomes. Within the Targeted Training in Illness Management arm, those with anxiety disorders had significantly greater improvement in mental health functioning. Those with anxiety comorbidity in the Targeted Training in Illness Management group demonstrated significantly lower HbA1c levels compared to no anxiety comorbidity and also demonstrated a greater improvement in HbA1c over the first 30 weeks compared to those without anxiety comorbidity.

Conclusion

Comorbid anxiety in serious mental illness and type II diabetes mellitus population is associated with increased psychiatric symptomatology and greater disability. Individuals from this population appear to experience greater improvement in functioning from baseline with the Targeted Training in Illness Management intervention. Anxiety comorbidity in the serious mental illness and type II diabetes mellitus population does not appear to have a negative impact on diabetic control. These complex relationships need further study.

Clinical Trials Registration

ClinicalTrials.gov: Improving outcomes for individuals with serious mental illness and diabetes (NCT01410357).

Keywords

comorbidity medical illness mental illness psychiatry

Get full access to this article

View all access options for this article.

References

Kessler

Chiu

Demler

et al . Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617–627.

Buckley

Miller

Lehrer

et al . Psychiatric comorbidities and schizophrenia. Schizophr Bull 2009; 35: 383–402.

Preti

Vrublevska

Veroniki

et al . Prevalence, impact and treatment of generalised anxiety disorder in bipolar disorder: a systematic review and meta-analysis. Evid Based Mental Health 2016; 19: 73–81.

Karpov

Joffe

Aaltonen

et al . Anxiety symptoms in a major mood and schizophrenia spectrum disorders. Eur Psychiatry 2016; 37: 1–7.

Pallanti

Quercioli

and Hollander

Social anxiety in outpatients with schizophrenia: a relevant cause of disability. Am J Psychiatry 2004; 161: 53–58.

Braga

Mendlowicz

Marrocos

et al . Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life. J Psychiatr Res 2005; 39: 409–414.

Achim

Maziade

Raymond

et al . How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 2011; 37: 811–821.

Regenold

Thapar

Marano

et al . Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 2002; 70: 19–26.

Mitchell

and Malone

Physical health and schizophrenia. Curr Opin Psychiatry 2006; 19: 432–437.

10.

van Winkel

De Hert

Van Eyck

et al . Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord 2008; 10: 342–348.

11.

Mitchell

and Dinan

TG.

Schizophrenia: a multisystem disease?

J Psychopharmacol 2010; 24: 5–7.

12.

Schoepf

Potluri

Uppal

et al . Type-2 diabetes mellitus in schizophrenia: increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up. Eur Psychiatry 2012; 27: 33–42.

13.

Mitchell

Vancampfort

Sweers

et al . Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders – a systematic review and meta-analysis. Schizophr Bull 2013; 39: 306–318.

14.

Chwastiak

Davydow

McKibbin

et al . The effect of serious mental illness on the risk of rehospitalization among patients with diabetes. Psychosomatics 2014; 55: 134–143.

15.

Fiore

Marci

Poggi

et al . The association between diabetes and depression: a very disabling condition. Endocrine 2015; 48: 14–24.

16.

Gunzler

Sajatovic

McCormick

et al . Psychosocial features of clinically relevant patient subgroups with serious mental illness and comorbid diabetes. Psychiatr Serv 2017; 68: 96–99.

17.

Guo

Keck

Jr Corey-Lisle

et al . Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: a retrospective, population-based, case-control study. J Clin Psychiatry 2006; 67: 1055–1061.

18.

Guo

Keck

Jr Corey-Lisle

et al . Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study. Pharmacotherapy 2007; 27: 27–35.

19.

Harley

Corey-Lisle

et al . Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population. Soc Psychiat Epidemiol 2007; 42: 690–697.

20.

Erickson

Zakharyan

et al . New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder. J Am Geriatr Soc 2012; 60: 474–479.

21.

Garcia-Rizo

Kirkpatrick

Fernandez-Egea

et al . Abnormal glycemic homeostasis at the onset of serious mental illnesses: a common pathway. Psychoneuroendocrinology 2016; 67: 70–75.

22.

Blixen

Kanuch

Perzynski

et al . Barriers to self-management of serious mental illness and diabetes. Am J Health Behav 2016; 40: 194–204.

23.

Smith

Beland

Clyde

et al . Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res 2013; 74: 89–99.

24.

Grigsby

Anderson

Freedland

et al . Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res 2002; 53: 1053–1060.

25.

Anderson

Grigsby

Freedland

et al . Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med 2002; 32: 235–247.

26.

Smith

Pedneault

and Schmitz

Investigation of anxiety and depression symptom co-morbidity in a community sample with type 2 diabetes: associations with indicators of self-care. Can J Public Health 2016; 106: e496–e501.

27.

Whitworth

Bruce

Starkstein

et al . Lifetime depression and anxiety increase prevalent psychological symptoms and worsen glycemic control in type 2 diabetes: the Fremantle Diabetes Study Phase II. Diabetes Res Clin Pract 2016; 122: 190–197.

28.

Wykes

Lee

McKibbin

et al . Self-efficacy and hemoglobin A1C among adults with serious mental illness and type 2 diabetes: the roles of cognitive functioning and psychiatric symptom severity. Psychosom Med 2016; 78: 263–270.

29.

Blixen

Perzynski

Kanuch

et al . Training peer educators to promote self-management skills in people with serious mental illness (SMI) and diabetes (DM) in a primary health care setting. Prim Health Care Res Dev 2015; 16: 127–137.

30.

Sajatovic

Gunzler

Kanuch

et al . A 60-Week Prospective RCT of a Self-Management Intervention for Individuals With Serious Mental Illness and Diabetes Mellitus. Psychiatr Serv 2017; 68: 883–890.

31.

Bajor

Gunzler

Einstadter

et al . Associations between comorbid anxiety, diabetes control, and overall medical burden in patients with serious mental illness and diabetes. Int J Psychiatry Med 2015; 49: 309–320.

32.

Bandura

Organisational applications of social cognitive theory. Aust J Manage 1988; 13: 275–302.

33.

Bauer

and McBride

Structured group psychotherapy for bipolar disorder: the life goals program. New York, NY: Springer Publishing Company, 2003.

34.

McKibbin

Patterson

Norman

et al . A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res 2006; 86: 36–44.

35.

Lawless

Kanuch

Martin

et al . A nursing approach to self-management education for individuals with mental illness and diabetes. Diabetes Spectr 2016; 29: 24–31.

36.

Kanuch

Cassidy

Kristin

et al . Recruiting and retaining individuals with serious mental illness and diabetes in clinical research: lessons learned from a randomized, controlled trial. J Health Dispar Res Pract 2016; 9: 8.

37.

Sheehan

Lecrubier

Sheehan

et al . The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22–33. quiz 4–57.

38.

Overall

and Gorham

DR.

The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799–812.

39.

Montgomery

and Asberg

A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382–389.

40.

Guy

The clinical global impression scale. The ECDEU assessment manual for psychopharmacology revised. Vol. DHEW Publ No ADM 76-338. Rockville, MD: US Department of Health, Education, and Welfare. Public Health Service, Alcohol, Drug Abuse, Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research, 1976, pp.218–222.

41.

Jones

Thornicroft

Coffey

et al . A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry 1995; 166: 654–659.

42.

Leon

Olfson

Portera

et al . Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med 1997; 27: 93–105.

43.

Ware

Jr and Sherbourne

CD.

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–483.

44.

Chaudhry

Jin

and Meltzer

Use of a self-report-generated Charlson comorbidity index for predicting mortality. Med Care 2005; 43: 607–615.

45.

Balhara

and Sagar

Correlates of anxiety and depression among patients with type 2 diabetes mellitus. Indian J Endocrinol Metab 2011; 15: S50–S54.

46.

Brown

Kim

Mitchell

et al . Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 2010; 196: 116–121.

47.

Kalra

and Balhara

YP.

Psychological assessment and management in diabetes. J Pak Med Assoc 2013; 63: 1555–1557.

48.

Trento

Raballo

Trevisan

et al . A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes. Acta Diabetol 2012; 49: 199–203.

49.

Trento

Trevisan

Raballo

et al . Depression, anxiety, cognitive impairment and their association with clinical and demographic variables in people with type 2 diabetes: a 4-year prospective study. J Endocrinol Invest 2014; 37: 79–85.

50.

Siegelaar

Holleman

Hoekstra

et al . Glucose variability; does it matter? Endocr Rev 2010; 31: 171–182.

51.

Salehi

Cordero

and Sandi

Learning under stress: the inverted-U-shape function revisited. Learn Mem 2010; 17: 522–530.